Versatile Coating via Programmed Assembly of miR‐155 Inhibitor and Endothelial Affinity Peptide
Source abstract
Abstract
ABSTRACT Medical implants serve as pivotal therapeutic interventions for cardiovascular diseases. Nevertheless, challenges including endothelial injury, excessive smooth muscle cell migration, and inflammatory responses associated with implantation hinder their long‐term adoption in vivo. In this work, a versatile coating of cardiovascular implants was constructed by the remarkable adhesive properties of dopamine and the precision and efficiency of click chemistry. The functional coating was obtained through programmed assembly of heparin, miR‐155 inhibitor, and endothelial cell affinity peptide. Cellular experiments have demonstrated that this coating could modulate macrophage phenotype through anti‐miR155 inhibitors, thereby inhibiting the release of inflammatory factors and improving the inflammatory environment on the surface. Furthermore, this coating could also promote the adhesion and proliferation of endothelial cells while inhibiting the excessive proliferation of smooth muscle cells, thereby ensuring the endothelialization of the implant surface. Additionally, animal experiments have revealed the coating's exceptional anticoagulant properties, significantly reducing the formation of thrombus. With its simple and efficient preparation process and excellent performance, this coating emerges as a promising candidate for promoting early endothelialization and improving the performance of cardiovascular implants.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Cell Adhesion Molecules Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Engineering Research Center for Biomaterials, Sichuan University Chengdu People's Republic of China
Chengdu NewMed Biotechnology Co. Ltd Chengdu People's Republic of China
Institute of Regulatory Science for Medical Device, Sichuan University Chengdu Sichuan Province People's Republic of China
Funding
Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China
References (29)
Show source-provided references
1. 10.1093/eurjpc/zwae28110.1093/eurjpc/zwae281 ↗
2. 10.1038/s41569-022-00720-x10.1038/s41569-022-00720-x ↗
3. Cardiovascular Stents: Types and Future Landscape
4. 10.1016/j.mtcomm.2022.10346710.1016/j.mtcomm.2022.103467 ↗
5. 10.1093/cvr/cvt09010.1093/cvr/cvt090 ↗
6. 10.1038/nrcardio.2012.6410.1038/nrcardio.2012.64 ↗
7. 10.1016/j.bioactmat.2022.04.03310.1016/j.bioactmat.2022.04.033 ↗
8. 10.1097/CRD.000000000000028310.1097/CRD.0000000000000283 ↗
9. 10.1038/s41598-022-26654-510.1038/s41598-022-26654-5 ↗
10. 10.1016/j.actbio.2019.08.04210.1016/j.actbio.2019.08.042 ↗
11. 10.1016/j.biomaterials.2021.12081610.1016/j.biomaterials.2021.120816 ↗
12. 10.1016/j.biomaterials.2022.12178510.1016/j.biomaterials.2022.121785 ↗
13. 10.4028/p-0tpt0610.4028/p-0tpt06 ↗
14. 10.1016/bs.apha.2017.08.01110.1016/bs.apha.2017.08.011 ↗
15. 10.1039/D0BM01396J10.1039/D0BM01396J ↗
16. 10.1039/D3BM00390F10.1039/D3BM00390F ↗
17. 10.1016/j.cjche.2020.11.02510.1016/j.cjche.2020.11.025 ↗
18. 10.1038/nri352010.1038/nri3520 ↗
19. 10.1126/scitranslmed.300892210.1126/scitranslmed.3008922 ↗
20. 10.1093/intimm/dxy05410.1093/intimm/dxy054 ↗
21. 10.1038/s41569-019-0265-310.1038/s41569-019-0265-3 ↗
22. 10.1016/j.jconrel.2023.01.02410.1016/j.jconrel.2023.01.024 ↗
23. 10.1038/s41577-021-00584-110.1038/s41577-021-00584-1 ↗
24. 10.3389/fphar.2022.107918510.3389/fphar.2022.1079185 ↗
25. 10.1016/j.apsb.2020.06.00510.1016/j.apsb.2020.06.005 ↗
26. 10.3389/fimmu.2019.0221710.3389/fimmu.2019.02217 ↗
27. 10.1021/acsbiomaterials.9b0029510.1021/acsbiomaterials.9b00295 ↗
28. 10.1021/acs.biomac.4c0089010.1021/acs.biomac.4c00890 ↗
29. 10.1016/j.colsurfb.2018.03.04710.1016/j.colsurfb.2018.03.047 ↗